Primo Partners with SHINE to Advance Precision Cancer Care in Asia-Pacific

Partnership Delivers Advanced Radioligand Treatments Across Asia-Pacific, Expanding Access to Cutting-Edge Cancer Therapies

Primo Biotechnology Partners with Antelope Surgical Solutions for World’s First FDA-Approved Phase I/II Trial of AS1986NS

Primo wins 2023 TAIPEI Prominent Enterprise Award

Primo Biotechnology Raises Over 6.5 Million USD in Funding, Pioneering an International-level Radiopharmaceutical Manufacturing Facility

Dr. Chi-Wei Chang joins Primo as CTO of Radiopharmaceutical Chemistry.

Tackle Cancer Challenge

May 1 – May 15, 2022

Are Asian Countries Ready for Novel Radiopharmaceuticals?

Dr. Ya-Yao Huang Act as an Ambassador of Oncidium